Kennedy Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-249,569	Closed	-$5.61M	–	697
2023 Q1	$5.61M	Sell	249,569 -33,774	-12%	-$760K	0.17%	231
2022 Q4	$5.96M	Buy	283,343 +117,114	+70%	+$2.46M	0.17%	210
2022 Q3	$4.1M	Buy	+166,229	New	+$4.1M	0.12%	301